FDA Inspection 1159676 — Bray Group Limited

Bray Group Limited — FEI 3003217321

The FDA completed an inspection of Bray Group Limited on September 30, 2021 in Faringdon. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 30, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Faringdon (United Kingdom)

Additional Details

Mutual Recognition Agreement (MRA)